Languages
Pages
Legal
Explore all categories to find your favorite topic
EUnetHTA JA2 WP7 Multi-HTA Early Dialogues Mira Pavlovic, MD François Meyer, MD HAS, EUnetHTA JA2 WP7 Lead Partner 2 Collaborative EUnetHTA actions Relevant EUnetHTA* ongoing…
Dec2015 ©EUnetHTA, 2015. Reproduction is authorised provided EUnetHTA is explicitly acknowledged 1 EUnetHTA Joint Action 3 WP4 Version 1.4, 26.11.2019 This report is part…
European network for Health Technology Assessment JA2 2012-2015 www.eunethta.eu To view drawing guides 1. Right-click on slide and select ’Grid and Guides...’ 2. Check…
Dec2015 ©EUnetHTA, 2015. Reproduction is authorised provided EUnetHTA is explicitly acknowledged 1 EUnetHTA Joint Action 3 WP4 Version 2.0, September 2020 Template version…
EUnetHTA European network for Health Technology Assessment EUnetHTA â The European network for Health Technology Assessment EUnetHTA Training Course for Stakeholders Rome,…
Dec2015 ©EUnetHTA 2015 Reproduction is authorised provided EUnetHTA is explicitly acknowledged 1 EUnetHTA Joint Action 3 WP4 Version 15 21st November 2019 This report is…
EUnetHTA Joint Action 3 WP4 Version 1, 28 July 2020 This report is part of the project / joint action ‘724130 / EUnetHTA JA3’ which has received funding from
E U n e t H T A INTERIM REPORT YEAR 2006 The EUnetHTA-project is supported by a grant fr the European Commission om E U R O P E A N N E T W O R K F O R H E A L T H T E C…
NEWSLETTER N° 138 – June 2016 Avenue Marnix 30 - BE-1000 BRUSSELS l wwwhopebe HOPE is an international non-profit association under Belgian law CONTENT Click on a title…
EUnetHTA Joint Action 2010–2012 wwweunethtaeu REA of Pharmaceuticals Collaboration between EMA and EUnetHTA Development of consensus on HTA methodologies Mira Pavlovic…
EUnetHTA JA2 - HTA Core Model 3.0 - www.htacoremodel.info Appendices European Network for Health Technology Assessment EUnetHTA JA2 WP8 DELIVERABLE HTA Core Model Version…
European network for Health Technology Assessment JA3 2016-2020 wwweunethtaeu HTA body HTAb experience on joint scientific advice early dialogues EMAHTA with ATMPs Chantal…
The EUnetHTA JA 2010-2012 received funding from the European Union, in the framework of the Health Programme E U R O P E A N N E T W O R K F O R H E A L T H T E C H N O L…
EUnetHTA European network for Health Technology Assessment wwweunethtaeu Joint Action 2010–2012 EUnetHTA Joint Action 2010–2012 wwweunethtaeu Results of the EUnetHTA…
Sonia García Pérez Agencia Española de Medicamentos y Productos Sanitarios The EUnetHTA Experience – Lessons Learned for a New EU HTA Cooperation EUnetHTA - AEMPS European…
Type here The EUnetHTA JA 2 2012-2015 has received funding from the European Union, in the framework of the Health Programme EUnetHTA JA2 WP2 DELIVERABLE Report of yearly…
8/11/2019 EUnetHTA JA FinalTechnicalReport2010 2012FinalVersion20130531 0 1/160The EUnetHTA JA (2010-2012) received funding fromthe European Union, in the framework of the…
EUnetHTA Joint Action 3 WP4 Version 1.0, 12/03/2020 BROLUCIZUMAB FOR THE TREATMENT OF ADULTS WITH NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION (AMD) Project ID: PTJA09
Cefiderocol For the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options Submitted by: Shionogi Disclaimer: The sole responsibility
The EUnetHTA JA 2010-2012 received funding from the European Union, in the framework of the Health Programme E U R O P E A N N E T W O R K F O R H E A L T H T E C H N O L…